The North America cell expansion market is expected to reach US$ 14,697.41 Mn in 2027 from US$ 4,522.07 Mn in 2019. The market is estimated to grow with a CAGR of 15.9% from 2019-2027.
The growth in North America is characterized by characterized by increasing prevalence of cancer across the region, new product launches and increasing inclination of patients towards regenerative and personalized medicines. Also, growing R&D expenditure for cancer research are likely to have a positive impact on the growth of the market in the coming years. But, risk of contamination associated with the cell expansion process is likely to hinder the growth of the Cell Expansion market in the future years.
Regenerative medicine has the potential to replace or heal tissues as well as organs damaged by age, disease, or trauma, as well as to normalize congenital defects. Over the last quarter of a century, there has been an emergence of a tissue engineering industry, one that has now evolved into the broader area of regenerative medicine. Regenerative medicine is defined as a rapidly growing interdisciplinary field that involves engineering sciences to develop clinical therapies intended for maintenance, repair, replacement and enhancement of biological function. Cell expansion is a crucial and invariable part of regenerative medicine. On the bases of study and investigation, desired regeneration techniques are used to develop the tissue which involves cell expansion procedures. It helps to understand how to treat injuries and diseases from broken bones to neurodegenerative diseases. Thus, the rise in the adoption of regenerative medicines is expected to foster the demand for cell expansion technique thereby driving the market growth.
In 2019, US accounted the largest market share in the North America cell expansion market, and it is also expected to grow at a faster pace over the forecast period. US is an economically advanced country and the country has presence of various players that are well established in the biotechnology market. The companies are engaged in the research and development activities that are enabling them to develop latest cell therapies and personalized medicines for various diseases. Moreover, the increasing awareness about new therapies in the country is also responsible to stimulate the market growth.
Mexico Cell Expansion Market Revenue and Forecasts to 2027 (US$ Mn)
NORTH AMERICA CELL EXPANSION – MARKET SEGMENTATION
By Modality
-
Consumables
- Reagents, Media and Serum
-
Disposables
- Culture Tissue Flasks
- Bioreactor Accessories
- Other Disposables
-
Instruments
- Cell Expansion Supporting Equipment
- Bioreactors
- Automated Cell Expansion Systems
By Modality
-
Human Cells
- Adult Stem Cells
- Induced Pluripotent Stem Cells
- Embryonic Stem Cells
- Differentiated Cells
- Animal Cells
By Application
- Regenerative Medicine and Stem Cell Research
- Cancer and Cell-based Research
- Other Applications
By End User
- Biopharmaceutical and Biotechnology Companies
- Research Institutes
- Cell Banks
- Other End Users
By Geography
-
North America
- US
- Canada
- Mexico
Company Profiles
- BD
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Terumo Corporation
- General Electric Company
- Corning Incorporated
- Miltenyi Biotec
- Danaher
- Lonza
- STEMCELL TECHNOLOGIES, INC.
North America Cell Expansion Market Strategic Insights
North America Cell ExpansionMarket Report Highlights
| Report Attribute | Details |
| Market size in 2019 | US$ 4,522.07 Million |
| Market Size by 2027 | US$ 14,697.41 Million |
| CAGR (2019 - 2027) | 15.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
North America Cell Expansion Market Country and Regional Insights
